LoginRegister
    Torrent Pharma says promoters havent pledged sharesTorrent Pharma says promoters haven't pledged shares
    Govt tightens export ban norms for anti-malarial drug hydroxychloroquineGovt tightens export ban norms for anti-malarial drug hydroxychloroquine
    USFDA Requests Removal of All Ranitidine Products (Zantac) from the MarketUSFDA Requests Removal of All Ranitidine Products (Zantac) from the Market
    Cipla completes Phase-3 clinical study for generic version of GSK Advair DiskusCipla completes Phase-3 clinical study for generic version of GSK Advair Diskus
    CDSCO releases procedure for lot release of Human vaccine in view of prevailing COVID-19 pandemicCDSCO releases procedure for lot release of Human vaccine in view of prevailing COVID-19 pandemic
    Pfizer receives European approval for Oncology Biosimilar, RUXIENCE (rituximab)Pfizer receives European approval for Oncology Biosimilar, RUXIENCE (rituximab)
    Thermo Fisher Scientific to enhance capacity for COVID-19 testing in IndiaThermo Fisher Scientific to enhance capacity for COVID-19 testing in India
    DeepTek Medical Imaging collaborates with Japanese MBM for AI- lead solution to screen CoronavirusDeepTek Medical Imaging collaborates with Japanese MBM for AI- lead solution to screen Coronavirus
    Bristol Myers Squibb, bluebird bio announce submission of BLA for Myeloma Drug to USFDABristol Myers Squibb, bluebird bio announce submission of BLA for Myeloma Drug to USFDA
    Lupin gets USFDA EIR for Aurangabad FacilityLupin gets USFDA EIR for Aurangabad Facility
    HUL completes GSK merger, buys Horlicks in Rs 3,045 croresHUL completes GSK merger, buys Horlicks in Rs 3,045 crores
    AstraZeneca divestment of Movantik to RedHill Biopharma completedAstraZeneca divestment of Movantik to RedHill Biopharma completed
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X